Exploring DALT. To explore a different substance…

Names:
DALT · N,N-Diallyltryptamine · Indole, 3-[2-(Diallylamino)ethyl] · Tryptamine, N,N-Diallyl · 3-[2-(Diallylamino)ethyl]indole
IUPAC name:
N-[2-(1H-Indol-3-yl)ethyl]-N-(prop-2-en-1-yl)prop-2-en-1-amine
ID: 5372 · Formula: C16H20N2 · Molecular weight: 240.343
InChI: InChI=1S/C16H20N2/c1-3-10-18(11-4-2)12-9-14-13-17-16-8-6-5-7-15(14)16/h3-8,13,17H,1-2,9-12H2

Brandt, SD; Tirunarayanapuram, SS; Freeman, S; Dempster, N; Barker, SA; Daley, PF; Cozzi, NV; Martins, CPB. Microwave-accelerated synthesis of psychoactive deuterated N,N-dialkylated-[α,α,β,β-d4]-tryptamines. J. Labelled Compd. Radiopharm., 1 Nov 2008, 51 (14), 423–429. 169 kB. http://dx.doi.org/10.1002/jlcr.1557

Brandt, SD; Kavanagh, PV; Dowling, G; Talbot, B; Westphal, F; Meyer, MR; Maurer, HH; Halberstadt, AL. Analytical characterization of N,N-diallyltryptamine (DALT) and 16 ring-substituted derivatives. Drug Test. Analysis, 1 Jan 2017, 9 (1), 115-126. 1.3 MB. http://dx.doi.org/10.1002/dta.1974 Open access DOI

Dinger, J; Woods, C; Brandt, SD; Meyer, MR; Maurer, HH. Cytochrome P450 inhibition potential of new psychoactive substances of the tryptamine class. Toxicol. Lett., 2016, 241, 82-94. 2.6 MB. http://dx.doi.org/10.1016/j.toxlet.2015.11.013

Cozzi, NV; Daley, PF. Receptor binding profiles and quantitative structure–affinity relationships of some 5-substituted-N,N-diallyltryptamines. Bioorg. Med. Chem. Lett., 2016, 26 (3), 959-964. 513 kB. http://dx.doi.org/10.1016/j.bmcl.2015.12.053

Meyer, MR; Caspar, A; Brandt, SD; Maurer, HH. A qualitative/quantitative approach for the detection of 37 tryptamine-derived designer drugs, 5 β-carbolines, ibogaine, and yohimbine in human urine and plasma using standard urine screening and multi-analyte approaches. Anal. Bioanal. Chem., 1 Jan 2014, 406 (1), 225–237. 457 kB. http://dx.doi.org/10.1007/s00216-013-7425-9

DBT
DET
DIPT
DMT
DPT
EIPT
MBT
MIPT
NET
NMT
T
NIPT
N-HO-NMT
NCPT
PIPT
BIPT
MET
MPT
NPT
NBT
NIBT
NSBT
NTBT
NAT
NHT
5558
5559
N-Benzyltryptamine
5565
5566
DIBT
EPT
MIBT
MSBT
DSBT
N-Formyltryptamine
5601
5602
5603
5604
5605
5606
5607
5608
5609
5610
5611
5612
5613
5614
5615
5616
5617
5618
5619
5620
5621
5622
5623
5624
5625
5626
5627
5628
5629
5630
5631
5632
5633
5634
5635
5636
5637
5638
5639
5640
5641
5642
5643
5645
5646
5647
5648
5649
5650
tert-Butyl N-[2-(1H-indol-3-yl)ethyl]-N-methylglycinate
N2-[2-(1H-Indol-3-yl)ethyl]-N2-methylglycinamide
5653
5654
DAT
DHT
HOT-T
4-HO-DALT
4-AcO-DALT
4-MeO-DALT
5-MeO-DALT
5-EtO-DALT
pyr-T
pip-T
mor-T
5073
5074
Gramine
dmpyrrol-T
mepipaz-T
Homotryptamine
DBT
DET
DIPT
DMT
DPT
EIPT
MBT
MIPT
NET
NMT
T
NIPT
N-HO-NMT
NCPT
PIPT
BIPT
MET
MPT
NPT
NBT
NIBT
NSBT
NTBT
NAT
NHT
5558
5559
N-Benzyltryptamine
5565
5566
DIBT
EPT
MIBT
MSBT
DSBT
N-Formyltryptamine
5601
5602
5603
5604
5605
5606
5607
5608
5609
5610
5611
5612
5613
5614
5615
5616
5617
5618
5619
5620
5621
5622
5623
5624
5625
5626
5627
5628
5629
5630
5631
5632
5633
5634
5635
5636
5637
5638
5639
5640
5641
5642
5643
5645
5646
5647
5648
5649
5650
tert-Butyl N-[2-(1H-indol-3-yl)ethyl]-N-methylglycinate
N2-[2-(1H-Indol-3-yl)ethyl]-N2-methylglycinamide
5653
5654
DAT
DHT
HOT-T
4-HO-DALT
4-AcO-DALT
4-MeO-DALT
5-MeO-DALT
5-EtO-DALT
pyr-T
pip-T
mor-T
5073
5074
Gramine
dmpyrrol-T
mepipaz-T
Homotryptamine
30 April 2017 · Creative Commons BY-NC-SA ·